2
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81075 |
SUCNR1-IN-2
|
||
SUCNR1-IN-2 (Statement 35) 作为succinate/succinate受体 1 抑制剂,专用于神经退行性疾病(例如神经炎症)的研究领域。 | |||
T79207 | SUCNR1-IN-1 | ||
SUCNR1-IN-1(Compound 20)是针对SUCNR1的抑制剂,IC50值为88 nM(针对hSUCNR1)。该化合物可应用于类风湿关节炎、肝纤维化以及肥胖相关研究。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03256 |
CNR1 Protein, Rat, Recombinant (His)
Skr6,Brain-type cannabinoid receptor,Cannabinoid receptor |
Rat | E. coli |
CNR1 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 58.9 kDa and the accession number is P20272. | |||
TMPH-01035 |
CNR1 Protein-VLP, Human, Recombinant (His)
Cnr1,Skr6,CB1,CB-R,Cannabinoid re... |
Human | HEK293 Cells |
CNR1 Protein-VLP, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-10xHis tag. The predicted molecular weight is 54.6 kDa and the accession number is P21554. | |||
TMPY-06623 |
CB2/CNR2 Protein, Human, Recombinant
CB2,CB-2,CX5 |
Human | HEK293 Cells |
Genetic variants within the CNR2 gene encoding the cannabinoid receptor CB2 are associated with osteoporosis and low bone mineral density (BMD) in case-control studies. There is a possibility that genetic variants of the CNR1 gene may produce a liability to the complication of psychotic state after abuse of methamphetamine. |